What’s Hot in HIV Treatment: Expert Discussion
Introduction (5 minutes)
Case Discussion: Navigating Current ART Options (10 minutes)
Case Discussion: Individualizing ART Based on Evolving Safety and Tolerability Data (10 minutes)
Case Discussion: Optimizing ART in Women (10 minutes)
Expert Dialogue: Update on ART Strategies Under Investigation (10 minutes)
Question and Answer (15 minutes)
Date / Time
Monica Gandhi, MD, MPH
Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California
Linda-Gail Bekker, FCP(SA), PhD, MBChB, DTM&H, DCH, FCP(SA), PhD
Chief Operating Officer
Desmond Tutu HIV Foundation
Desmond Tutu HIV Centre
Immediate Past President
International AIDS Society
Faculty of Health Sciences
University of Cape Town,
Cape Town, South Africa
Pedro Cahn, MD, PhD
Senior Consultant, Infectious Diseases
Hospital Juan Fernández
Director, Fundación Huesped
Professor of Infectious Diseases
Buenos Aires University Medical School
Buenos Aires, Argentina
Laura Waters, MD
Consultant Physician, HIV/GU Medicine
Mortimer Market Centre
CNWL NHS Trust
London, United Kingdom
This program is designed to improve clinician performance and patient outcomes through evidence-based expert presentations and case-based discussion on topics immediately relevant to optimal care of patients with HIV infection. This activity will feature a 40-minute pre-recorded, on-demand, didactic session followed by a 60-minute live panel discussion among expert faculty.
The goal of this activity is to improve the knowledge and competence of learners in optimizing and individualizing HIV treatment for each patient, including the appropriate integration of new and emerging ART strategies.
The program is intended for physicians, pharmacists, and other healthcare professionals who provide care for people at risk of, or living with, HIV.
Upon completion of this activity, participants should be able to:
- Integrate newer ART agents into the care of people living with HIV
- Appropriately evaluate and manage emerging adverse events associated with ART
- Provide individualized care for key populations of patients living with HIV, such as women
- Critically appraise the current and future role of emerging paradigms for ART
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity or enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-20-062-L02-P
Type of Activity: Knowledge
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.